Molecular Human Reproduction Vol. 2, NUMBER 5 pp. 371-382, 1996
© European Society of Human Reproduction and Embryology 1996
research-article |
Recombinat hormones: Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon®)
NV Organon, PO Box 20, 5340 BH Oss, The Netherlands
To whom correspondence should be addressed at: 1To whom correspondence should be addressed
Follicle stimulating hormone (FSH) is a heterodimeric glycoprotein hormone produced in the anterior pituitary gland. The hormone is essential in the regulation of reproductive processes, such as follicular development and ovulation. It is clinically used for treatment of anovulation and in assisted reproduction technologies such as in-vrtro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Until recently, the only source for human FSH has been the urine from post-menopausal women. Such a natural source implies limited availability and potential product variability. Thus, we have cloned the genes encoding the 
- and ß-subunrts of human FSH and transfected these into Chinese hamster ovary (CHO) cells. A CHO-clone was isolated capable of secreting intact glycosylated FSH with identical amino acid sequences to natural FSH. This cell line was grown in perfusion culture and enabled us to isolate highly pure FSH (>99%). The complexity of the charge distribution of human recombinant FSH was demonstrated by isoelectric focusing. The observed microheterogeneity is caused by the large number of carbohydrate chain structures which are added to the four potential glycosylation sites in the ß-dimer. Furthermore, the carbohydrates show a variation in their degree of sialylation which reflects the different pl values of the individual isohormones. Despite the complexity of post-translational modification, the isoform distribution of recombinant FSH produced in a CHO-cell line and grown in perfusion culture is surprisingly similar to that observed with pituitary FSH and urinary FSH. In conclusion, we have shown that FSH-gene transfected CHO-cells are capable of stable serum-free production of recombinant FSH. A process has been developed which assures the consistent and reproducible production of highly-purified recombinant FSH.
FSH/heterologous gene expression/isohormones/peptide mapping/recombinant glycoprotein hormone
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Aizen, H. Kasuto, M. Golan, H. Zakay, and B. Levavi-Sivan Tilapia Follicle-Stimulating Hormone (FSH): Immunochemistry, Stimulation by Gonadotropin-Releasing Hormone, and Effect of Biologically Active Recombinant FSH on Steroid Secretion Biol Reprod, April 1, 2007; 76(4): 692 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Demirol and T. Gurgan Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study Hum. Reprod., January 1, 2007; 22(1): 97 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Lunenfeld Historical perspectives in gonadotrophin therapy Hum. Reprod. Update, November 1, 2004; 10(6): 453 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Perlman, B. van den Hazel, J. Christiansen, S. Gram-Nielsen, C. B. Jeppesen, K. V. Andersen, T. Halkier, S. Okkels, and H. T. Schambye Glycosylation of an N-Terminal Extension Prolongs the Half-Life and Increases the in Vivo Activity of Follicle Stimulating Hormone J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3227 - 3235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Platteau, E. Laurent, C. Albano, K. Osmanagaoglu, V. Vernaeve, H. Tournaye, M. Camus, A. Van Steirteghem, and P. Devroey An open, randomized single-centre study to compare the efficacy and convenience of follitropin {beta} administered by a pen device with follitropin {alpha} administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI Hum. Reprod., June 1, 2003; 18(6): 1200 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gervais, Y.-a. Hammel, S. Pelloux, P. Lepage, G. Baer, N. Carte, O. Sorokine, J.-m. Strub, R. Koerner, E. Leize, et al. Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency Glycobiology, March 1, 2003; 13(3): 179 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J.M. Duijkers, C. Klipping, P. J. Boerrigter, C. S.M. Machielsen, J. J. de Bie, and G. Voortman Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females Hum. Reprod., August 1, 2002; 17(8): 1987 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Balasch, E. Vidal, J. Penarrubia, R. Casamitjana, F. Carmona, M. Creus, F. Fabregues, and J. A. Vanrell Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH Hum. Reprod., August 1, 2001; 16(8): 1636 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ricci, G. Tamaro, R. Simeone, E. Giolo, G. Nucera, F. De Seta, and S. Guaschino Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH Hum. Reprod., March 1, 2001; 16(3): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Olivares, M. Cardenas, C. Timossi, T. Zarinan, V. Diaz-Sanchez, and A. Ulloa-Aguirre Reactivity of different LH and FSH standards and preparations in the World Health Organization matched reagents for enzyme-linked immunoassays of gonadotrophins Hum. Reprod., November 1, 2000; 15(11): 2285 - 2291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Horsman, J.A. Talbot, J.D. McLoughlin, A. Lambert, and W.R. Robertson A biological, immunological and physico-chemical comparison of the current clinical batches of the recombinant FSH preparations Gonal-F and Puregon Hum. Reprod., September 1, 2000; 15(9): 1898 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Matorras, V. Recio, B. Corcostegui, and F.J. Rodriguez-Escudero Recombinant human FSH versus highly purified urinary FSH: a randomized study in intrauterine insemination with husbands' spermatozoa Hum. Reprod., June 1, 2000; 15(6): 1231 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lenton, A. Soltan, J. Hewitt, A. Thomson, W. Davies, N. Ashraf, V. Sharma, L. Jenner, W. Ledger, and E. McVeigh Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP) Hum. Reprod., May 1, 2000; 15(5): 1021 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Frydman, C.M. Howles, and F. Truong A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F(R)) with highly purified urinary FSH (Metrodin(R) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection Hum. Reprod., March 1, 2000; 15(3): 520 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H.M. Hoomans, A. N. Andersen, A. Loft, R. A. Leerentveld, A. A. van Kamp, and H. Zech A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon(R)) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP(R)) in a fixed-dose regimen in women undergoing ovarian stimulation Hum. Reprod., October 1, 1999; 14(10): 2442 - 2447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Daya and J. Gunby Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction Hum. Reprod., September 1, 1999; 14(9): 2207 - 2215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U.A. Vitt,, H.J. Kloosterboer,, U.M. Rose,, J.W.M. Mulders,, P.S. Kiesel,, S. Bete,, and P.L. Nayudu Isoforms of Human Recombinant Follicle-Stimulating Hormone: Comparison of Effects on Murine Follicle Development In Vitro Biol Reprod, October 1, 1998; 59(4): 854 - 861. [Abstract] [Full Text]
|
|